YieldMax MSTR Option Income Strategy ETF (MSTY) Stock Price Today
Aura AI Summary
Key Stats
- -Market Cap
- -Volume
- Income / Options OverlaySector
- $114.3052W High
- $11.5552W Low
- -Typical Hold Time
- -Enterprise Value
- -Div Yield
- -Trading Activity
Track YieldMax MSTR Option Income Strategy ETF (MSTY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, YieldMax MSTR Option Income Strategy ETF has traded between a low of $11.55 and a high of $114.3, highlighting its annual price range. Buy and sell YieldMax MSTR Option Income Strategy ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About YieldMax MSTR Option Income Strategy ETF
MSTY is an actively managed ETF that pursues a synthetic covered call strategy on MicroStrategy Incorporated (MSTR) stock. The fund primarily sells call options on MSTR and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the volatile, Bitcoin-correlated growth potential of MSTR while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Most Recent News
Global silicon interposer market to reach $14B by 2035, driven by AI and advanced chip tech growth.
The global silicon interposer market, valued at $4 billion in 2025, is projected to grow to $14.04 billion by 2035 with a CAGR of 13.38%. Growth is fueled by rising adoption of AI, chiplet architectures, and advanced semiconductor packaging technolog...

AI in spintronics market to hit $7.11B by 2030 with 30.9% CAGR, driven by AI integration and low-power memory demand
The AI in spintronics market is projected to grow from $2.42 billion in 2026 to $7.11 billion by 2030, expanding at a CAGR of 30.9%. Growth is fueled by AI integration in spintronic design, demand for energy-efficient memory, and advances in magnetic...

Basel Medical regains Nasdaq compliance after share price recovers above $1.00
Basel Medical Group Ltd announced it has regained compliance with Nasdaq's minimum bid price rule after its share price stayed at or above $1.00 for 10 consecutive business days ending July 7, 2026. The company was previously notified in January 2026...
